ArticleGlomerular diseases

Designing Clinical Trials for the Treatment of Membranous Nephropathy in the Anti-Phospholipase A2 Receptor 1 Era: Results of a NephCure Membranous Nephropathy Workshop.

Marco Prunotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.